avandia news

Winder & Counsel, PC
175 West 200 South, Suite 4000
Salt Lake City, Utah 84101

(866) 322-2243 (toll free)
(801) 322-2222

info@windercounsel.com

Avandia News

 

Lawyers Provide Latest News on Avandia Lawsuits and Side Effects

 
Winder & Counsel provides the latest news on lawsuits involving Avandia and information on the drug's side effects. avandia recall

Avandia: When Does a Drug's Harm Outweigh Its Benefit?

 
Los Angeles Times | July 1, 2010

It's scary enough that a widely prescribed diabetes drug, Avandia, was shown in new studies this week to pose a substantially greater risk of heart attacks for users.

But what should really get consumers freaked is that healthcare experts and federal regulators say this isn't really surprising. When it comes to drug safety, they say, you can't make an omelet without breaking a few eggs.

FDA Issues Strictest Warnings on Avandia

The New York Times | June 7, 2007

The Food and Drug Administration has called for the toughest safety warning on two diabetes drugs, Avandia and Actos, whose health risks have become a docus of Congressional concern.

That decision, disclosed on Wednesday by the FDA commissioner at a packed House hearing, comes more than a year after the agency's safety reviewers strongly recommended such a step. And it occurs amid a Congressional investigation into why the agency delayed its warnings about Avandia for years.

Doctor Says Drug Maker Tried to Quash His Criticism of Avandia

 
The New York Times | June 2, 2007

When a Congressional committee holds a hearing next Wednesday, the subject will be the safety of the diabetes drug Avandia and whether federal drug regulators have paid close enough attention to its potential risks.

But for one witness who is scheduled to appear, Dr. John B. Buse, a nationally noted diabetes specialist, the hearing will take a different turn, focusing on whether he was the target of an effort by the drug's maker, GlaxoSmithKline, to silence his criticism of the drug.

Senator Says FDA Was Lax on Label for Avandia

 
The New York Times | May 25, 2007

Federal regulators did not act on a recommendation from their safety reviewers several months ago that GlaxoSmithKline's diabetes drug Avandia should carry the strongest possible caution about heart attacks, Senator Charles Grassley said Thursday in a statement.

Mr. Grassley, Republican of Iowa, said in a statement that some Food and Drug Administration staff members had concluded that prescribing information for the medicine should include a warning framed by a black box, the most serious type of alert.

Winder & Counsel presently is investigating legal claims against the manufacturer of Avandia. We invite you to contact us for a free, confidential consultation about your legal rights.

About Our Law Firm

The law firm of Winder & Counsel, PC was formed in 1983. The firm is composed of experienced and highly respected lawyers who represent numerous and varied clients.

The firm has successfully represented thousands of people in matters of local, national and international significance.

These include litigation against tobacco companies, dangerous pharmaceuticals, injuries from all types of accidents, medical malpractice, wrongful death, the September 11th Class Action, the first lawsuit by military personnel unter anti-terrorism statutes, and Prempro, Celebrex, Vioxx and other litigation.

Contact Us

Name
Phone
Email
 

Avandia News

Avandia: When Does a Drug's Harm Outweigh Its Benefit?
Los Angeles Times | July 1, 2010

FDA Issues Strictest Warning on Avandia
The New York Times | June 7, 2007

Doctor Says Drug Maker Tried to Quash His Criticism of Avandia
The New York Times | June 2, 2007